Denis Curtin

Denis Curtin

Auto-generated profile, based on publicly available information

Denis Curtin

Department of Medicine, University College Cork, Cork, Ireland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2020 in Age and Ageing
Verified
Journal Article
Closed access
PDF file
DCDenis Curtin
Denis Curtin
PGPaul Gallagher
Paul Gallagher
DODenis O’mahony
Denis O’mahony
Background: Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy (STOPPFrail) criteria were developed in 2017 to assist physicians with deprescribing decisions in older people approaching end-of-life. Updating was required to make the tool more practical, patient-centred and complete. Methods: a thorough literature review was conducted to, first, devise a practical method for identifying older people who are likely to be approaching end-of-life, and second, reassess and update the existing deprescribing criteria. An eight-member panel with a wide-ranging experience in geriatric pharmacotherapy reviewed a new draft of STOPPFrail and were invited to propose new deprescribing criteria. STOPPFrail version 2 was then validated using Delphi consensus methodology. Results: STOPPFrail version 2 emphasises the importance of shared decision-making in the deprescribing process. A new method for identifying older people who are likely to be approaching end-of-life is included along with 25 deprescribing criteria. Guidance relating to the deprescribing of antihypertensive therapies, anti-anginal medications and vitamin D preparations comprises the new criteria. Conclusions: STOPPFrail criteria have been updated to assist physicians in efforts to reduce drug-related morbidity and burden for their frailest older patients. Version 2 is based on an up-to-date literature review and consensus validation by a panel of experts.

23 December 2019 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
DCDenis Curtin
Denis Curtin
EJEmma Jennings
Emma Jennings
RDRuth Daunt
Ruth Daunt
SCSara Curtin
Sara Curtin
MRMary Randles
Mary Randles
DODenis O'MAhony
Denis O'MAhony

23 April 2018 in Age and Ageing
Verified
Journal Article
Open access
PDF file
DCD Curtin
D Curtin
DOD O’mAhony
D O’mAhony
PGP Gallagher
P Gallagher
The last year of life for many older people is associated with high symptom burden and frequent hospitalizations. Hospital physicians have an opportunity to prioritize essential medications and deprescribe potentially futile medications. to measure medication consumption during hospitalization in the last year of life and the prevalence of potentially inappropriate medications (PIMs) at hospital discharge. retrospective chart review. acute hospital. ≥65 years, hospitalized in the last year of life. medication consumption was determined by examining hospital Medication Administration Records. PIMs were defined using STOPPFrail deprescribing criteria. the study included 410 patients. The mean age of participants was 80.8, 49.3% were female, and 63.7% were severely frail. The median number of days spent in hospital in the last year of life was 32 (interquartile range 15−59). During all hospitalizations, the mean number of individual medications consumed was 23.8 (standard deviation 10.1). One-in-six patients consumed 35 or more medications in their last year. Over 80% of patients were prescribed at least one PIM at discharge and 33% had ≥3 PIMs. Lipid-lowering medications, proton pump inhibitors, anti-psychotics and calcium supplements accounted for 59% of all PIMs. Full implementation of STOPPFrail recommendations would have resulted in one-in-four long-term medications being discontinued. high levels of medication consumption in the last year of life not only reflect high symptom burden experienced by patients but also continued prescribing of futile medications. Physicians assisted by the STOPPFrail tool can reduce medication burden for older people approaching end of life.

12 November 2018 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
DCDenis Curtin
Denis Curtin
TDTim Dukelow
Tim Dukelow
KJKirstyn James
Kirstyn James
DODesmond O’dOnnell
Desmond O’dOnnell
DODenis O’mAhony
Denis O’mAhony
PGPaul Gallagher
Paul Gallagher

2 June 2020 in Age and Ageing
Verified
Journal Article
Closed access
KDKieran Dalton
Kieran Dalton
DCDenis Curtin
Denis Curtin
DODenis O’mAhony
Denis O’mAhony
SBStephen Byrne
Stephen Byrne
Background: findings from a recent qualitative study indicate that the perceived clinical relevance of computer-generated STOPP/START recommendations was a key factor affecting their implementation by physician prescribers caring for hospitalised older adults in the SENATOR trial. Aim: to systematically evaluate the clinical relevance of these recommendations and to establish if clinical relevance significantly affected the implementation rate. Methods: a pharmacist–physician pair retrospectively reviewed the case records for all SENATOR trial intervention patients at Cork University Hospital and assigned a degree of clinical relevance for each STOPP/START recommendation based on a previously validated six-point scale. The chi-square test was used to quantify the differences in prescriber implementation rates between recommendations of varying clinical relevance, with statistical significance set at P < 0.05. Results: in 204 intervention patients, the SENATOR software produced 925 STOPP/START recommendations. Nearly three quarters of recommendations were judged to be clinically relevant (73.6%); however, nearly half of these were deemed of ‘possibly low relevance’ (320/681; 47%). Recommendations deemed of higher clinical relevance were significantly more likely to be implemented than those of lower clinical relevance (P < 0.05). Conclusions: a large proportion (61%) of the computer-generated STOPP/START recommendations provided were of potential ‘adverse significance’, of ‘no clinical relevance’ or of ‘possibly low relevance’. The adjudicated clinical relevance of computer-generated medication recommendations significantly affects their implementation. Meticulous software refinement is required for future interventions of this type to increase the proportion of recommendations that are of high clinical relevance. This should facilitate their implementation, resulting in prescribing optimisation and improved clinical outcomes for multimorbid older adults.

3 May 2019 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
DCDenis Curtin
Denis Curtin
DDDarren L. Dahly
Darren L. Dahly
MSMaarten van Smeden
Maarten van Smeden
DODesmond P. O'DOnnell
Desmond P. O'DOnnell
DDDavid Doyle
David Doyle
DODenis O'MAhony
Denis O'MAhony